Xbiotech Inc
(XBIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,324 | 46,793 | 64,798 | 78,225 | 91,051 |
| TOTAL | $36,930 | $48,841 | $66,328 | $79,839 | $93,041 |
| Non-Current Assets | |||||
| PPE Net | 10,142 | 10,082 | 9,779 | 7,715 | 5,946 |
| Other Non-Current Assets | 19,978 | 19,369 | 17,094 | 13,708 | 10,371 |
| TOTAL | $30,120 | $29,451 | $26,873 | $21,423 | $16,317 |
| Total Assets | $67,050 | $78,292 | $93,201 | $101,262 | $109,358 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,431 | 4,465 | 8,494 | 4,846 | 4,825 |
| Accrued Expenses | 3,532 | 2,176 | 1,882 | 1,717 | 1,466 |
| TOTAL | $7,963 | $6,641 | $10,376 | $6,563 | $6,291 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 23 | 22 | 21 | 20 | 17 |
| TOTAL | $23 | $22 | $21 | $20 | $17 |
| Total Liabilities | $7,986 | $6,663 | $10,397 | $6,583 | $6,308 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,149 | 32,464 | 32,443 | 32,351 | 32,292 |
| Common Shares | 242,419 | 238,808 | 237,523 | 235,751 | 233,902 |
| Retained earnings | -183,412 | -167,013 | -154,529 | -140,908 | -130,651 |
| Other shareholders' equity | 57 | -166 | -190 | -164 | -201 |
| TOTAL | $59,064 | $71,629 | $82,804 | $94,679 | $103,050 |
| Total Liabilities And Equity | $67,050 | $78,292 | $93,201 | $101,262 | $109,358 |